Table 9.
Urine pH for the Experimental group with daily PA, SRWC, and PRAL subgroup analyses (Mean (SE)).
| Experimental Condition | Pre-Treatment Period | Treatment Period | Post-Treatment Period | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | M11 | M12 | |
| All Subjects | 6.28 | 6.20 | 6.22 | 6.25 | † 6.51 | † 6.57 | † 7.00 | † 7.00 | † 7.07 | 6.23 | 6.17 | 6.21 |
| (n = 19) | (0.11) | (0.11) | (0.10) | (0.10) | (0.09) | (0.10) | (0.12) | (0.11) | (0.08) | (0.07) | (0.10) | (0.09) |
|
Low PA (n = 9) |
6.34 (0.16) |
6.40 (0.18) |
6.32 (0.12) |
6.32 (0.12) |
6.54 (0.13) |
6.63 (0.12) |
† 6.88 (0.12) |
† 6.89 (0.13) |
† 6.94 (0.08) |
6.34 (0.11) |
6.24 (0.17) |
6.33 (0.17) |
|
High PA (n = 10) |
6.23 (0.15) |
6.02 (0.12) |
6.11 (0.14) |
6.04 (0.09) |
6.48 (0.11) |
† 6.67 (0.13) |
† 7.15 (0.13) |
† 7.12 (0.13) |
† 7.10 (0.13) |
6.13 (0.12) |
6.11 (0.12) |
6.11 (0.12) |
|
Low SRWC (n = 9) |
6.17 (0.09) |
6.26 (0.14) |
6.33 (0.09) |
6.21 (0.10) |
6.30 (0.08) |
6.29 (0.12) |
6.34 (0.11) |
6.54 (0.11) |
† 6.60 (0.11) |
6.16 (0.11) |
6.11 (0.09) |
6.09 (0.08) |
|
High SRWC (n = 10) |
5.91 (0.16) |
5.96 (0.18) |
6.00 (0.16) |
6.29 (0.17) |
† 6.57 (0.17) |
† 6.78 (0.11) |
† 7.21 (0.12) |
† 7.14 (0.14) |
† 7.25 (0.08) |
6.07 (0.16) |
5.88 (0.15) |
6.27 (0.12) |
|
Low PRAL (n = 9) |
6.56 (0.15) |
6.40 (0.16) |
6.46 (0.12) |
6.41 (0.13) |
6.50 (0.11) |
6.50 (0.14) |
† 6.79 (0.20) |
† 6.88 (0.20) |
† 6.89 (0.14) |
6.40 (0.10) |
6.32 (0.15) |
6.37 (0.14) |
|
High PRAL (n = 10) |
6.04 (0.11) |
6.02 (0.13) |
5.99 (0.15) |
6.19 (0.15) |
† 6.63 (0.14) |
† 6.65 (0.14) |
† 7.15 (0.13) |
† 7.18 (0.13) |
† 7.24 (0.07) |
6.07 (0.12) |
6.04 (0.12) |
6.07 (0.08) |
Note: There were a total of twelve 24-hour urine collections labeled in the table as M1-M12, respectively.
† Mean pH value differed significantly (P < 0.05) from respective mean Pre-Treatment reference value which was an average of all M1-M3 values within the condition and subject group being evaluated. These Pre-Treatment reference values were as follows: 6.23 (all Experimental subjects), 6.35 (low PA), 6.12 (high PA), 6.33 (low SRWC), 5.96 (high SRWC), 6.47 (low PRAL), and 6.02 (high PRAL).